For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Control BM Arm | Conventional bone marrow transplant (BM) | None | None | 1 | 13 | 8 | 13 | View |
| Experimental G-BM Arm | G-CSF (filgrastim) stimulated bone marrow (G-BM) | None | None | 0 | 13 | 7 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Abdominal pain | None | Gastrointestinal disorders | None | View |
| Anemia | None | Blood and lymphatic system disorders | None | View |
| Anorexia | None | Metabolism and nutrition disorders | None | View |
| Autoimmune disorder | None | Immune system disorders | None | View |
| Bladder infection | None | Infections and infestations | None | View |
| Blood bilirubin increased | None | Investigations | None | View |
| Death NOS | None | General disorders | None | View |
| Edema face | None | General disorders | None | View |
| Epistaxis | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Hematuria | None | Renal and urinary disorders | None | View |
| Hepatobiliary disorders - Other, specify | None | Hepatobiliary disorders | None | View |
| Hyperglycemia | None | Metabolism and nutrition disorders | None | View |
| Hypokalemia | None | Metabolism and nutrition disorders | None | View |
| Hyponatremia | None | Metabolism and nutrition disorders | None | View |
| Hypoxia | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Infections and infestations - Other, specify | None | Infections and infestations | None | View |
| Lung infection | None | Infections and infestations | None | View |
| Lymphocyte count decreased | None | Investigations | None | View |
| Mucositis oral | None | Gastrointestinal disorders | None | View |
| Multi-organ failure | None | General disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Neutrophil count decreased | None | Investigations | None | View |
| Oral pain | None | Gastrointestinal disorders | None | View |
| Peripheral nerve infection | None | Infections and infestations | None | View |
| Pharyngitis | None | Infections and infestations | None | View |
| Pharyngolaryngeal pain | None | Respiratory, thoracic and mediastinal disorders | None | View |
| Platelet count decreased | None | Investigations | None | View |
| Rectal mucositis | None | Gastrointestinal disorders | None | View |
| Renal and urinary disorders - Other, specify | None | Renal and urinary disorders | None | View |
| Skin infection | None | Infections and infestations | None | View |
| White blood cell decreased | None | Investigations | None | View |